Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Great Novel Therapeutics Biotech & Medicals Corporation

Clinical trials sponsored by Great Novel Therapeutics Biotech & Medicals Corporation, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental drug chidamide targets Hard-to-Treat blood cancer Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Experimental drug chidamide targets Hard-to-Treat blood cancer

Disease control Recruiting now

This phase II trial tests the drug chidamide in people with peripheral T-cell lymphoma that has come back or stopped responding to treatment. The study aims to see if chidamide can shrink tumors and how safe it is. Participants take chidamide twice a week, and doctors monitor the…

Phase 2 • Sponsor: Great Novel Therapeutics Biotech & Medicals Corporation • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC